Drug intelligence / Profile preview

Vikair

Development stage
Unknown
Lead developer
Pharmstandard
Modality
Small Molecules
Administration
Oral
01

Overview

Vikair is a multi-component combination drug widely used in Russia and other CIS countries for the treatment of acid-related gastrointestinal disorders, including peptic ulcers and hyperacid gastritis. The formulation consists of bismuth subnitrate, magnesium carbonate, sodium bicarbonate, calamus rhizome powder, and frangula bark powder. Bismuth subnitrate acts as a gastroprotective agent by forming a protein-bismuth complex that coats ulcerated tissue and exhibits antimicrobial activity against *Helicobacter pylori*. The magnesium and sodium salts serve as antacids to neutralize gastric hydrochloric acid, while the herbal components provide mild antispasmodic and laxative properties to counteract the constipating effects of bismuth and magnesium. It is typically administered orally as a tablet.

Brand names
Vikair
Other names
ВикаирBismuth subnitrate + Magnesium carbonate + Sodium bicarbonate + Calamus rhizome + Frangula bark
02

Targets

PEP (Pepsin)

Beyond the preview

Go deeper on Vikair.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vikair.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call